The molecular characterization of ESC RCC by next generation sequencing (NGS) revealed recurrent and mutually exclusive somatic bi-allelic loss or mutations in of TSC gene family, including TSC2 and TSC1 in 85% (6/7) of evaluated cases [13]. The gene discussed is TSC1; the disease is renal cell carcinoma.